US FDA approves a weight loss drug for treating ‘serious' fatty liver disease; here's what you need to know
This approval marks a major advancement in liver disease treatment, as MASH is a progressive condition caused by fat buildup and inflammation in the liver. Often symptomless in its early stages, the disease can silently progress to cirrhosis, liver failure, or liver cancer if untreated. By targeting both weight reduction and liver health, semaglutide offers a dual benefit for patients at high risk. Experts see this as a breakthrough, providing the first effective pharmacological option for millions affected by fatty liver disease, which is rapidly emerging as a global health concern.
These results suggest semaglutide is not just managing risk factors like weight and blood sugar but is directly improving liver health, offering new hope for patients who previously had no effective drug treatment options.
What is the link between fatty liver and diabetes mellitus?
What is MASH? Understanding the fatty liver disease
MASH (previously called non-alcoholic steatohepatitis or NASH) is a severe form of fatty liver disease. It usually begins as metabolic-associated fatty liver disease (MAFLD), where fat gradually builds up in the liver due to poor metabolism.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Many Filipinos don't know about this!
Allthebestloans.ph
Read More
Undo
Early stage (MAFLD): Excess fat is stored in the liver but often without symptoms.
Progression to MASH: Over time, fat accumulation triggers inflammation and cell injury.
Advanced stage (Fibrosis and Cirrhosis): Continuous inflammation leads to scarring (fibrosis), which reduces liver function. Severe scarring, known as cirrhosis, may result in liver failure or cancer.
Why early detection is difficult
Most patients remain unaware of MASH because symptoms develop only in later stages. When present, they may include:
Abdominal discomfort or pain
Fatigue and low energy
Loss of appetite and weight loss
Jaundice (yellowing of eyes and skin)
This makes screening and preventive treatment crucial, especially for people who are overweight, diabetic, or have high cholesterol.
MASH and obesity: How Semaglutide is changing liver disease treatment
MASH is closely linked to obesity, diabetes, and metabolic syndrome. With the rise of these conditions globally, MASH has become one of the leading causes of chronic liver disease.
Until recently, doctors only recommended lifestyle interventions such as diet control, weight loss, and regular exercise. In 2023, the FDA approved Resmetirom, the first medicine for MASH. Now, semaglutide's approval adds another option — but with a different working mechanism. Semaglutide belongs to a class of drugs known as GLP-1 receptor agonists. It was first approved in 2017 for type 2 diabetes and later for obesity management and heart disease prevention.
In MASH patients, semaglutide helps by:
Reducing body weight and abdominal fat, which lowers liver fat storage
Improving insulin resistance, a key factor in fatty liver buildup
Lowering systemic inflammation, reducing liver injury
This makes semaglutide particularly useful in patients who have both obesity and fatty liver disease.
Source: The New York Times
FDA approves semaglutide medication for MASH after strong clinical trial results
The FDA based its approval on results from a large phase III clinical trial involving 800 participants across multiple centers.
534 patients received semaglutide; 266 received a placebo.
After 72 weeks, results showed:
63% of patients on semaglutide had resolution of MASH without worsening liver scarring.
Only 34% in the placebo group achieved the same.
When looking at liver fibrosis (scarring):
37% of semaglutide users showed improvement, compared to 22% in the placebo group.
The trial is ongoing for 240 weeks (around 4.5 years) to determine whether these improvements can lower risks of death, liver transplant, or severe complications.
MASH in India: A growing health challenge
India is witnessing a rapid increase in metabolic liver diseases, driven by rising obesity, sedentary lifestyles, and high rates of diabetes.
As reported, studies estimate that 9% to 32% of Indians may be living with MAFLD, the starting point of MASH.
A 2025 study of IT employees in Hyderabad revealed alarming trends:
84% had excess liver fat
76.5% had high cholesterol levels
70.7% were obese
20.9% had elevated fasting blood sugar
These numbers reflect the strong connection between urban lifestyles, poor diet, and fatty liver disease in India's working population.
Also Read |
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
23 minutes ago
- Time of India
Colon cancer on the rise among youngsters: 5 warning symptoms that should not be ignored
Colon cancer, a leading cause of cancer-related deaths, is increasingly affecting younger individuals. Those born in 1990 face twice the risk compared to those born in 1950. Changes in bowel habits, rectal bleeding, abdominal pain, unexplained weight loss, and persistent fatigue are crucial warning signs. Early diagnosis and awareness are vital for improved treatment outcomes and survival. Colon cancer is the second leading cause of cancer-related deaths worldwide. While this cancer predominantly affects older individuals (aged 50 and above), it is increasingly being diagnosed in younger people. A recent study suggests that compared to people born in 1950, those born in 1990 have twice the risk of developing colon cancer. Lifestyle factors such as poor diet, lack of physical activity, obesity, smoking, and alcohol consumption play a crucial role in the early onset. Early diagnosis is crucial for treatment outcomes and survival. This is why awareness around the disease, its symptoms, and prevention is crucial. Here are some of the warning symptoms of colon cancer you should not ignore. Take a look. Changes in bowel habits If you notice any changes in your poop, do not ignore them. Yes, that's right. How you poop really matters. Studies have consistently shown that colorectal patients complain of changes in bowel habits. Any changes, such as constipation, diarrhea, narrowing, or frequency of your poop, should not be dismissed. If these symptoms persist lasts more than a few weeks, you should consult your healthcare provider. Blood in your poop Rectal bleeding is a hallmark sign of colon cancer. Studies have shown that rectal bleeding, along with other factors, is predictive of colorectal cancer. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like American Investor Warren Buffett Recommends: 5 Books For Turning Your Life Around Blinkist: Warren Buffett's Reading List Undo If you notice blood in the poop on toilet paper, consult your doctor right away. The presence of blood can appear as dark or bright red patches in the poop. Though other conditions, such as hemorrhoids, too, could lead to rectal bleeding, it is important to find out the cause behind it. Belly pain An ache in your abdominal area is another significant sign of colon cancer. If you experience pain in the belly, with no known cause, talk to your doctor. A 2024 study found that abdominal pain was the most common symptom (63%) in young patients with colorectal cancer. The pain may feel like cramps or bloating, and won't go away, and hurt a lot. Unexplained weight loss Weight loss is a common and often early symptom of colon cancer. If you notice sudden weight loss without a known reason, it should not be dismissed. Weight loss, without even changing your diet or fitness levels, should be a cause of concern. This sign is noticeable, and you shouldn't ignore it. 6 Foods that help you poop better and relieve constipation in the morning Constant fatigue If you experience persistent tiredness, it's a red flag. Feeling tired, even after a good night's sleep, is a common symptom in people with colon cancer. Fatigue is not normal. The lack of energy should not be dismissed. Talk to your doctor if you notice this sign, along with other symptoms.
Economic Times
26 minutes ago
- Economic Times
Over 5,000 pounds of cheese recalled amid Listeria contamination concerns—here's what you should know
A significant cheese recall is underway in Ohio. Middlefield Original Cheese Co-op recalls cheese due to possible Listeria contamination. The recall involves several cheese types. These include pepper jack and cheddar. Consumers are advised to check lot codes. Affected products were distributed in July and August 2025. No illnesses have been reported yet. Tired of too many ads? Remove Ads What cheese products are affected? Tired of too many ads? Remove Ads What makes Listeria contamination so risky? Tired of too many ads? Remove Ads What should people do next? FAQs Federal inspectors have raised worries about contamination with a pathogen that might be dangerous, leading to a huge cheese recall Middlefield Original Cheese Co-op is taking thousands of pounds of its best-selling items off the market in Ohio. People are being told to check their refrigerators right FDA has announced a huge recall of more than 5,000 pounds of cheese made by Middlefield Original Cheese Co-op because testing showed that it could have been contaminated with Listeria Ohio-based business is withdrawing its items off shop shelves on its own and telling customers to take safeguards right away, as per a recall includes a number of popular types of cheese, such as pepper jack, cheddar, Monterey Jack, farmers, and horseradish-flavored cheeses. The business says that the bad items were created on June 16, June 24, and July 16, 2025, and that they were sent to shops in Ohio between July 14 and August should carefully verify the lot codes on their cheese. The recall includes the following products, as per a report:Middlefield Original Cheese Co-op Pepper Jack Cheese is 100% grass-fed. It comes in 8 oz. containers, 5 lb. loaves, and 40 lb. loaves (Lot Code 251661).Copia Collective Pepper Jack Cheese (8 oz. containers, Lot Code 251661) is made from 100% grass-fed Original Cheese Co-op Horseradish Cheese (8 oz. packets, Lot Code 2524061)Monterey Jack Cheese comes in 8 oz. and 5 lb. blocks with Lot Code 251672 and 40 lb. blocks with a date of Cheese: 8 oz. packages and 5 lb. blocks with Lot Code 251672 and 40 lb. blocks with dates coded as 7-16-25BListeria is a kind of bacterium that may be found in food and is known to pose major health hazards, especially to people who are already weak. The Centers for Disease Control and Prevention (CDC) say that over 1,600 individuals in the United States get sick from Listeria every year, and about 260 of those people die, as per a who are healthy may just have flu-like symptoms, including fever, nausea, diarrhea, or stomach discomfort. But for pregnant women, babies, pensioners, and those with weak immune systems, infections might cause consequences that could kill them. It can also lead to miscarriage or stillbirth during pregnancy, as per a Original Cheese Co-op has said that thus far, no illnesses have been related to the recall. But officials are telling consumers not to take any chances. If you bought the cheese that was recalled, you should throw it away right away or take it back to the store where you bought it for a full minimize cross-contamination, the FDA also says that refrigerators, cutting boards, and utensils that may have come into contact with the cheese should be cleaned thus far, there have been no illnesses associated with this should throw away the cheese or take it back for a full refund.
Time of India
an hour ago
- Time of India
High on hope: Rehab retention hits record in Ludhiana, centres keep addicts hooked on recovery.
Ludhiana: Govt-run deaddiction centres in this Punjab district have reported a sharp rise in patient retention, with more than 61% of addicts remaining in treatment this year as opposed to just 41% in 2020. Health experts claim that the increase reflects greater access to outpatient opioid assisted treatment (OOAT) services and expanded availability of medicines such as buprenorphine across the district. At civil hospital's Navjeevan Kendra, psychiatrist Dr Arvind Goyal said retention rates for men and women were almost equal, and that decentralising medicine distribution to local Nasha Mukti Dawai Kendras had made treatment more accessible. "Patients now get four to five days' supply at centres near their homes, which keeps them engaged in therapy," Goyal said. He said the initiative, guided by civil surgeon Dr Ramandeep Kaur, aims to encourage patients to stay in treatment for a better life. Data from govt centres shows that retention rose to 52% in 2021, 56% in 2022, 57% in 2023, and 61% in 2024, with the figure reaching 61.6%, so far, in 2025. Of the 22,000 patients enrolled in Ludhiana district, 2,600 are registered at civil hospital. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like American Investor Warren Buffett Recommends: 5 Books For Turning Your Life Around Blinkist: Warren Buffett's Reading List Undo Also, 70-75% of them are addicted to heroin, 15% to poppy husk, and 5% to prescription drugs, tramadol mainly. Patients say the changes have made treatment more sustainable. A Sahnewal resident told The TOI that he had to travel to the city previously for medicines but could now access those at a nearby centre. "I don't have to spend on travel, and that makes it easier to continue," he said. Psychiatrists credit a mix of awareness drives, govt crackdowns on drug trafficking, and declining drug quality with pushing addicts toward treatment. Dr Anshu Gupta, a Ludhiana-based psychiatrist, said fear of the law and greater awareness of health risks had encouraged patients to stick with therapy. "Dropouts are much fewer now, and the trend is very positive," he said. MSID:: 123408301 413 | Stay updated with the latest local news from your city on Times of India (TOI). Check upcoming bank holidays , public holidays , and current gold rates and silver prices in your area.
